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That normal mice may harbor in their lungs a latent virus, capable of inducing 
fatal pneumonia in its natural host, was indicated in a  previous report  (1). 
The finding that this virus can induce manifest pulmonary infection in animals, 
which, under ordinary circumstances, harbor it with impunity, raises problems 
of  obvious  importance  to  a  fuller  knowledge  of  acute  respiratory  disease. 
Moreover it raises the possibility that latent infectious agents may play a sig- 
nitieant r61e in infections of the respiratory tract. 
A number of viruses have been procured by serial passage of mouse lungs during the past 
few years.  Most of these agents have been referred to as "mouse pneumonitis" viruses, or 
simply as "pneumonitis" viruses, and are now thought to belong in the so called psittacosis- 
lymphogranuloma venereum group of viruses (2).  In addition to the agents of this group, 
mice may harbor a latent pneumotropic virus which, to distinguish it, we have termed "pneu- 
monia virus of mice" (1).  For convenience this virus will be referred to in the present studies 
as PVM.  It should be emphasized that PVM  is to  be sharply discriminated from the so 
called mouse pneumonitis viruses and can be differentiated readily from these agents on the 
basis of the following characteristics:  (1) it does not form elementary bodies; (2) it is strictly 
pneumotropic;  (3)  it is not infectious for chick embryos;  (4)  it induces the development of 
solid  immunity against itself  following intraperitoneal injection in susceptible species;  (5) 
it is readily neutralized by specific  immune serum in high dilution; and (6)  it does not give 
complement fixation in the presence of such immune serum, except, as will be shown in a sub- 
sequent paper  (3)  under very special conditions. 
It is our belief that much may be learned concerning the factors responsible 
for acute respiratory disease in animals, as well as in man, through the intensive 
study of latent pneumotropic agents.  For this reason we have carried out a 
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detailed investigation on pneumonia virus of mice (PVM) and have attempted 
to place certain experimental procedures essential to the study of this agent 
upon as  quantitative a  basis as possible.  It is the purpose of this paper to 
report the results of studies on the reproducibility  of virus titratious with PVM, 
the reproducibility of neutralization tests with the virus and immune serum, 
the stability of the virus, and the effect of low gravitational fields upon it.  It 
will be shown that the immune serum dilution end point is a  function of the 
amount of virus used in a  neutralization test; that these two quantities bear 
an inverse exponential relationship, one to the other, which is linear. 
Methods 
Virus.--Pneumonia  virus of mice, strain 15 (1), was used throughout  this investigation. 
This strain of PVM was recovered from the lungs of albino Swiss mice in 1939 and since that 
time has been studied more than any other strain.  As was shown previously (1) all strains 
of PVM tested appeared to be immunologically  identical. 
The virus was maintained by occasional intranaml lung passage in albino Swiss mice, 
approximately 5 weeks of age.  Passages were made only when additional virus suspension 
was required; usually every 2nd or 3rd month.  Suspensions were prepared from the lungs 
of mice, which had been inoculated intranasally under light ether  anesthesia with PVM 5 
to 7 days previously.  The infected lungs were removed with aseptic precautions and were 
ground in a sufficient quantity of sterile beef infusion broth at pH 7.4 to give a 10 per cent 
suspension  by weight.  Such suspensions  were centrifuged at 1500 R.1,.~s.  for 10 or 1S minutes, 
and the superuates were used as virus source.  During the intervals between passages sus- 
pensions prepared  in this  manner were stored  at  -70°C. in a  cabinet containing  solid 
CO2 (4). 
Mice.--Albino  Swiss mice were used throughout  this study.  They were obtained each 
week from two commercial breeders in the vicinity of New York City and were from 4 to 5 
weeks of age upon arrival in the laboratory.  As far as could be determined, there was no 
significant difference in the susceptibility of mice obtained from these two breeders.  The 
great majority of experimental procedures were carried  out with mice received from one 
breeder. 
Normal mice were kept in large metal boxes in a room separate from that in which inocu- 
lated animals were under observation.  Following inoculation, groups of 5 or 6 animals were 
kept in individual glass battery jars with wire screen covers.  The animals were fed dally a 
mixture of whole wheat  bread,  freshly ground whole wheat  flour, milk, dried whole milk 
powder, and water; their total fluid intake was supplied in this mixture. 
Virus Titrations.--The  technique of virus fitratious used throughout this study was identi- 
cal with that used previously in similar studies on influenza A virus (5).  Serial dilutions in 
steps of either 1.0 or 0.5 log units of the virus suspension were prepared in sterile broth con- 
raining 10 per cent normal horse serum, which had been heated at 55°C. for 30 minutes and 
filtered through a Berkefeld N candle.  Each dilution was tested in a group of 5 or 6 mice; 
each mouse received 0.05 cc. intranasally under light ether  anesthesia.  Inoculated mice 
were observed daily; the lungs of those which died were examined for the presence and the 
extent of pneumonia, as were the lungs of those which survived  throughout the observation 
period of 11 to 12 days.  The method of calculation of virus titration end points is described 
below. 
Serum.--Immune serum against PVM was obtained from rabbits, cotton rats, and human 
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per cent saline suspension of mouse lungs infected with PViVI, while normal cotton rats were 
immunized by the intranasal injection of 0.25 cc. of a 10  -s dilution of virus suspension.  Serum 
was obtained from these animals approximately 3 weeks foLlowing injection.  The specimens 
of human serum used in this study were obtained from patients admitted to the Roekefeller 
Hospital  An sera were stored without preservative at 4°C. 
Neutralization Tes~.--The technique used in neutralization tests was identical with that 
employed previously in similar studies  on influenza A  virus  (5).  Serial dilutions in steps 
of 0.5 log units of virus suspension were each tested against a number of serial fivefold serum 
dilutions.  All sera were heated at 56°C. for 30 minutes before they were diluted.  As a rou- 
tine, each mixture of virus and serum contained 10 per cent normal horse serum which had 
been treated as described above, and mixtures were held for 30 to 60 minutes at 4°C. before 
mice were inoculated with them.  Each mixture of virus and serum was  inoculated intra- 
nasally into a group of six lightly anesthetized mice; each mouse was given 0.05 ce.  Neutrali- 
zation tests with each serum studied were repeated on at least three separate occasions.  At 
least two different suspensions of PVlVl were purposely used in tests with each serum, and each 
neutralization test was controlled by a  separate  titration  of virus done simultaneously in 
similar mice.  The observation of mice, the examination of their lungs, and the duration of 
the  observation period were identical to those described  above for virus  titrations.  The 
method of calculation of serum dilution end points is described below. 
Calculation of End Po/n~.--Both  the virus titration and  the serum dilution end points 
were calculated by the 50 per cent end point method of Reed and Muench (6).  It has been 
found that the so ca]led  30 per cent maximum score end point, described previously (5),  is 
considerably more reproducible with PVM, than either the 30 per cent mortality or the 50 
per cent pulmonary lesion end point.  It is of interest that Lauffer and Miller (7) recently 
showed that this weighted end point was also the most reproducible in their studies on in- 
fluenza A virus.  Throughout these studies all end points on virus titrations and neutraliza- 
tion tests refer to the 50 per cent maximum score value, which for convenience will be desig- 
nated as M.S. 50.  It is important to emphasize that this end point is influenced not only by 
the frequency with which fatal and non-fatal pneumonia is induced in mice, but also by the 
extent of the pulmonary consolidation which develops in each mouse. 
EXI~ER1"MENTAL 
Titration of PVl]Jf in Mice 
Before it was  possible  to evaluate accurately  the  significance  of differences 
in  virus  titration  end  points  with  PVM  following various procedures,  it  was 
necessary  to  determine  the  experimental  error;  i.e.,  the  expected  variation, 
of  such  titrations  with  this  virus. 
During a period of more than 2 years a large number of titrations of PVM in mice were 
carried out by the method described above.  Numerous different suspensions of mouse lungs 
infected with this agent were tested repeatedly, usually at intervals of 1 week.  Between 
tests the suspensions  were stored at  -70°C.  As will be shown below, suspensions of PVM 
stored under these conditions for as long as 78 days showed no signllieant alteration in titer. 
From four to ten separate virus titrations were carried out at different times on each of eleven 
different suspensions  of PVM.  The 50 per cent maximum score end point (M.S. 50)  was 
calculated, as described above, for each titration, and the geometric mean end point for each 
suspension was determined from all of the titrations done with it. 
The results of this series of titrations with PVlVI in mice are shown in Table 
I.  Each of the suspensions was initially centrifuged at  1,300 R.P.M. for 10 28  PNEI~ONIA  VIRUS Or  :MICE (PV~).  I 
or 15 minutes and suspensions 1 to 7 received no further centrifugation.  Sus- 
pensions 8  to 11,  however, were each centrifuged additionally at either 8,000 
or 10,000 l~.P.~, for 10 or 15 minutes before titrations were carried out. 
It will be seen that there was considerable variation among the individual 
titration end points obtained with each suspension, but that there was more 
marked variation between the mean end points found for different suspensions. 
It should be noted, however, that there was only slight variation in the mean 
values obtained with all of the suspensions at corresponding steps in the suc- 
cessive titrations.  Furthermore it will be noted that the mean end point found 
TABLE  I 
Results of Mulafle Titrations of PVM in Mice 
PVM  mouse lung 
suspension 
Centrl- 
•  ~ .  fugation 
R.P.M. 
1;soo 
~J 
--4.53 
--3.84 
--3.30 
--3.49 
--2.4! 
--3.18 
--5.00 
--3.55 
--3.56 
--4.6: 
--3.05 
--2.93 
--4.00 
--4.00 
--3.15 
--4.39 
--2.45 
--3.04 
M.S.50  end point 
Log 
Successive  titrations 
--4.20 
--3.57 
--2.73 
--5.00 
--3.03 
--2.33 
8  9 
--4.16  -- 
--4.50!  --3.5~ 
I 
24.331 -3.5~ 
--4.32  --3.5~ 
1-7  (Geo. Mean) 
8  8,000 
9  ~ 
10  I0,000 
II 
8-11  (Geo. mean) 
Total  (C~o. mean) 
--3.73 
--3.50 
--3.50 
--2.93 
--3.58 
--3.96 
--3.49 
--3,50 
--4.19 
--3.84 
--3.62 
--2.38 
--3.32 
--2.47 
--2.95 
--3.52 
--4.52 
--3.65 
--3.92 
--2.48 
--3.33 
--3.50 
--3.31 
--3.52 
--4.61 
--3.01 
--3.60 
--3.58 
--4.65 
--4.11 
--3.93 
--3.25 
--4.2( 
--2.86 
--3.76 
--3.78 
--3.71 
--3.27 
--2.28 
--3.22  I 
--2.9~ 
--3.47[ 
--3.64 
--2.63 
--2.00 
--3.35 
--2.91 
--2.72' 
--3.31 
--3.70 
--2.91 I 
--2.00' 
--2.4.  ¢ 
--3.2~ 
--4.42 
--3.65 
--4.13 
--4.07 I 
--2.4~ 
--2.4~ 
--3.61 
10 
--3.51 
--3.51 
 381[ 
Geo- 
metric 
mean 
--4.3~ 
--3.6~ 
--3.1~ 
--4.11 
--2.77 
--3.1~ 
--4.11 
--3.7~ 
--3.3 
.  --2.3~ 
--  --3.3~ 
--  --3.21 
--3.0C 
--3.49 
for four of the seven suspensions which were centrifuged only at 1,500 R.P.~r. 
was higher than the corresponding end point determined for any of the suspen- 
sions centrifuged at either 8,000  or  10,000 R.I~.~r.  The mean end point for 
suspensions 1 to 7 was greater by log 0.72, or 5.2 times, than the corresponding 
end point for suspensions 8 to 11. 
Since the mean end points obtained with all of the suspensions at correspond- 
ing steps  in the  successive  titrations  (i.e.  means found by vertical analysis 
of the data in Table I) were closely similar, whereas the mean end points ob- 
tained for each suspension (i.e. means found by horizontal analysis of the data 
in  Table  I)  were  widely dissimilar,  it  seemed probable  that  certain  of the 
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it appeared likely that suspensions which had been centrifuged at either 8,000 
or 10,000  1L1,.~r. usually contained less virus  than those which had  received 
only light  centrifugation. 
In order to determine the significance of the differences in end points shown in Table I, 
various computations were carried out with the available data.  The deviation of each in- 
dividual titration end point from the mean end point obtained for that particular suspension 
was found, and from this data the mean deviation of all the experimentally determined end 
points for each suspension was calculated.  The variance, V, of the end points obtained with 
TABLE  II 
Deviations, Variances, and Standard Deviations of Ti~rations of PVM in Mice 
M.S.  50 
No.  of  end  point  PVM mouse  lung  suspension titrations  Log 
No.  Centrifugation 
R.P.M. 
1  1,500 
2  " 
3 
4  " 
5 
6  " 
7  '$ 
1-7  (Geo. mean) 
8  8,000 
9  ~ 
10  10,000 
11  " 
8-11  (Geo. mean) 
Total  (Geo. mean) 
Deviation 
Standard 
Variance  deviation  From geometric mean 
Log 
Oeo.  Least  Greatest  Mean  V  ¢  mean 
8  --4.38  +0.04  +0.62  4-0.26  0.108  0.329 
7  --3.65  0.00  --0.64  4-0.23  0.110  0.332 
5  --3.19  --0.04  --0.46  4-0.20  0.087  0.295 
10  --4.11  +0.02  +0.89  4-0.45  0.287  0.536 
5  --2.77  +0.09  --0.32  4-0.25  0.088  0.297 
6  --3.13  +0.05  --0.80  4-0.37  0.257  0.507 
5  --4.17  +0.02  +0.48  4-0.33  0.172  0.415 
46  --3.72  4-0.04  4-0.60  4-0.31  0.149  0.386 
6  --3.30  --0.03  +0.62  4-0.37  0.225  0.474 
7  --2.36  --0.02  +0.57  4-0.23  0.103  0.321 
5  --3.36  --0.01  +0.22  +0.09  0.017  0.130 
4  --3.21  +0.29  +0.75  4-0.52  0.427  0.654 
22  --3.00  4-0.08  4-0.54  +0.29  0.147  0.384 
68  --3.49  4-0.05  4-0.58  4-0.31  0.146  0.383 
each suspension was also calculated, and from this value the standard deviation, a, of the 
distribution of individual end points was computed.  It will be recalled, as has been pointed 
out elsewhere (7), that, for small sample statistics, the variance is defined as the sum of the 
squares of the individual deviations from the mean divided by one less than the number of 
end points, and that the variance thus defined is equal to the square of the standard deviation. 
The  extensive  data  accumulated  in  this  series  of  computations  were 
condensed as  much as  possible  and  only those  which  were essential  to  the 
determination of variation in titrations with PVM are presented in Table II. 
The least and greatest deviations of end points for individual titrations from 
the mean end point for all titrations on the same  suspension, as well  as the 30  PNEUMONIA  VmUS  OF MICE @w).  i 
mean deviation found with each suspension  are  shown.  The variance and 
standard deviation of end points computed for each suspension are also given. 
It will be observed that the means of the least and greatest deviations for the 
entire series were log -4- 0.05 and 4- 0.58, respectively, and that the mean devia- 
tion of all the end points was log 4- 0.31.  It will also be noted that the standard 
deviation of the distribution of the end points for the whole series was 0.383 
log units.  It will be recalled that the standard deviation is, in fact, a measure 
of the reproducibility of end point determinations and consequently that this 
figure is essential before it is possible to determine with accuracy the significance 
of differences between end points.  It can be shown that with any two individ- 
ual end points determined on a single virus suspension, a difference of 2 X %/~ X 
the standard deviation, should occur only once  in 20  times.  Therefore,  in 
titrations with PVM, a difference between two individual  end points on different 
suspensions of 2 X  1.415 X 0.383 --  1.084 log units or more, can be taken to 
indicate that the chances are at least 19 out of 20 that the virus concentrations 
of the two suspensions  were  not identical.  A difference  of 1.084 log  units 
obviously corresponds to a twelvefold difference between titration end points. 
From the foregoing considerations  it can be shown that there is a very high 
probability that the differences between a  number of the mean end points 
shown in Table I were significant, and indicate that certain of the suspensions 
studied did in fact contain different concentrations of virus.  Thus, the proba- 
bility is at least 0.997 that suspensions 1, 4, and 7 contained a higher concentra- 
tion of virus than any of the other suspensions, excepting  only suspension  2, 
and that suspension 9 contained a lower concentration of virus than any other, 
excepting  only suspension 5.  Similarly the probability is at least 0.999 that 
the mean end point obtained with all the suspensions  centrifuged at either 
8,000 or  10,000 R.P.M. was significantly lower than that  found with all the 
suspensions which were merely centrifuged lightly. 
Susceptibility of Mice Obtained from Different Breeders 
One of the most important but least controllable factors which influences the 
reproducibility of virus titration end points is the susceptibility of the animal 
species in which tests are carried out.  If the degree of susceptibility remains 
relatively constant, the degree  of  variation encountered may not be  great. 
On the other hand, if for any reason susceptibility does not remain constant, 
enormous degrees of variation may result. 
It was shown previously (1) that titrations of PVM carried out simultane- 
ously in Swiss mice of similar age obtained from eight different breeders showed 
wide variations in end points.  It is now possible to show that some of the 
differences  observed  previously were  highly significant  and  indicated  that 
among the various stocks of mice tested there were in fact wide variations in 
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During the course of the present study Swiss mice were obtained for a time from a com- 
mercial breeder in Maine.  Titrations of PVM were carried out by the technique described 
above in these mice, and the same virus suspensions were also tested simultaneously in the 
other mice used throughout this study.  Moreover  attempts were made to carry out serial 
intranasal lung passages with PVM in the mice received from Maine, and also their serum 
was tested for the presence of neutralizing antibodies. 
It was found that the mean virus titration end point in mice received from 
Maine was less than log  --1.0 whereas the corresponding end point in mice 
obtained from the usual source was log -3.60.  It is obvious from the computa- 
tions given above that this difference in end points is highly significant.  Fur- 
thermore it was found that repeated attempts to carry out serial passages with 
PVM in the mice received from Maine were unsuccessful and in each instance 
the virus was lost.  It appears evident from the results of these experiments 
that these particular mice were almost, if not entirely resistant to infection with 
PVM.  It seems probable that their resistance was a  manifestation of active 
immunity to infection with the virus since numerous specimens of serum ob- 
tained from them showed high levels of neutralizing antibodies against PVM. 
In the light of these experiments and those previously reported, (1) it may be 
concluded that Swiss mice obtained from different sources may possess different 
degrees of susceptibility to infection with PVM. 
Effect of Centrifugation on Virus Titer 
The results of centrifugation and ultrafiltration experiments reported pre- 
viously (1) indicated that in our preparations PVM had a particle diameter of 
approximately 100  to  150  millimicrons.  On this basis it would be expected 
that centrifugation of suspensions of the virus at speeds up to 10,000 R.p.~r. for 
periods of 10 to 15 minutes should not cause a significant reduction in titer. 
None the less it has been repeatedly observed in this laboratory that such 
centrifugation did,  in fact, decrease the  titer of suspensions  of PVM.  The 
difference in the end points obtained with suspensions which had been lightly 
centrifuged, i.e. 1,500 lz.1,.~, for 10 to 15 minutes, and other suspensions which 
had been centrifuged at either 8,000 or 10,000 R.1,.~. for 10 to 15 minutes is 
shown in Table I.  Evidence was presented above which indicated that  the 
fivefold decrease in titer observed following centrifugation at the latter speeds 
had a high probability of being significant. 
Direct tests on the effect of centrifugation at either 8,000 or 10,000  1LP.~t. 
upon titration end points were carried with four separate suspensions of PVM 
which had received the usual light initial centrifugation.  Titrations were per- 
formed as described above both before and immediatoly after centrifugation at 
the higher speeds.  The results of these tests are shown in Table III.  It will 
be seen that the end point obtained with each of the suspensions was lower fol- 
lowing centrif~gation than before it.  The mean decrease in the titer with all 32  PNEtrMONnA vmus  or  ~ICE  (1,VM).  I 
the suspensions was log --0.93, which represents a reduction in the end point of 
8.5 times.  The probability is at least 0.999 that this decrease in titer is signifi- 
cant, and consequently it can be concluded that approximately 80 per cent of 
the virus was sedimented under the influence of the relatively low gravitational 
fields applied in these experiments.  These results might be considered as evi- 
dence that the original estimates of the particle diameter of PVM were in error 
and  that  the  virus  is  considerably larger than was  thought previously.  In 
another communication  (3) evidence will be presented which  indicates  that 
PVM is at least as small as was originally thought and may in fact be even 
smaller. 
TABLE  III 
Results of Titrations of PVM before and after High Speed Centrifugation 
PVM mouse lung 
suspension 
A 
B 
C 
D 
Centrifngation 
2,r.u.  [  Minutes 
10,000  10 
8,000  15 
7,  71 
Geometric mean ........................... 
M.S, 50 end point 
Log 
Before  After 
centrifugation  centrifugation 
-5.14  -3.96 
--2.57  --1.89 
-2.57  -1.79 
-3.13  -2.05 
--3.35  --2.42 
Change in M.S. 
50 end point 
following 
Centrifugation 
Log 
--1.18 
--0.68 
--0.78 
--1.08 
--0.93 
Effect of Storage on Titer of PVM 
The results of previous experiments (1) suggested that PVM is a very labile 
virus and becomes inactivated rapidly when held at room temperature in either 
broth or saline suspensions.  It was found, however, that the presence of normal 
horse serum in suspensions served to stabilize the virus and reduced the rate of 
inactivation. 
Before attempting to ascertain the reproducibility of immune serum dilution 
end points in neutralization tests with PVM, it appeared of importance to deter- 
'mine as precisely as possible the rate of inactivation of the virus at various tem- 
peratures.  It seemed probable that this information would be useful in the 
development of a reliable technique for neutralization tests with this agent. 
Suspensions of mouse lungs infected with PVM were prepared  as described above and to 
them sufficient normal horse serum was added to give a  concentration of 10 per cent.  These 
suspensions were kept for  various periods  at  22  °  to  28°C., 4°C.,  and  -70°C.  respectively. 
Titrations in mice were carried out as described above with each suspension before and im- 
mediately following the period of storage. 
The results of these titrations are shown in Table IV.  With four suspensions 
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in end point following storage was only log --0.37.  It will be noted, however, 
that with the suspension which was held for 24 hours at 28°C. a decrease in titer 
of lO00-fold or more occurred.  With six suspensions which were held at 4°C. 
TABLE IV 
Results of Titrations of PVM before and after Storage at  Various Tern 
PVM mouse  lung 
suspension 
a 
b 
C 
d 
Storage 
Temp.  Time 
°C. 
22  1} hrs. 
~  2 
"  2½ 
28  3 
"  6 
"  24 
Geometric mean* ......................... 
d 
e~ 
f 
h 
3 hrs. 
6 
24 
48 
PP 
Geometric mean .......................... 
J 
k 
1 
Ill 
--70  36 days 
48 
75 
78 
M.S. 50 end point 
Log 
~ef~:t~fes 
Before storage  After storage 
--2.93  --2.33 
--2.38  --2.18 
--2.97  --2.40 
--3.83  --3.75 
"  --3.45 
"  < --0.75 
--3.19  --2.82 
--3.83  --4.00 
"  -3.77 
"  --3.59 
--2.28  --2.00 
"  --2.48 
--2.57  --1.61 
--1.79  --1.41 
--2.57  --3.05 
--1.89  --1.75 
--2.76  --2.63 
--3.32  --3.22 
--2.45  --2.86 
--3.50  --2.91 
--3.49  --3.51 
--3.19  --3.12 
Change in  M.S. 
50 end point 
following 
storage 
Log 
--0.60 
--0.20 
--0.57 
--0.08 
--0.38 
;>--3.08 
--0.37 
+0.17 
--0.06 
--0.24 
--0.28 
+0.20 
--0.96 
--0.38 
+0.48 
--0.14 
-- 0.13 
-- 0.10 
+0.41 
-- 0.59 
+0.02 
Geometric mean ...........................  -  0.07 
* Results obtained with suspension d held for 24 hours were not included. 
Suspension was centrifuged at 8,000 R.p.xt. for 15 minutes before storage. 
for from 3  to 48 hours the mean reduction in end point following storage was 
only log --0.13.  Finally with four suspensions which were stored at  --70°C. 
for periods of from 36 to 78 days, the mean change in end point was no greater 
than log --0.07. 
By use of the standard deviation, 0.383 log units, found for the distribution of 34  PNEUMONL~ virus  oF M~CE (PvM).  I 
end points in titrations with PVM it can be shown that there was only one sig- 
nificant change in titer following storage in all of the tests carried out.  The 
marked decrease in titer which was observed with the suspension held for 24 
hours at 28°C. is highly significant, and indicates that almost all the virus was 
inactivated during this period.  It can be concluded from the results of these 
experiments that suspensions of PVM prepared as described above and contain- 
ing 10 per cent normal horse serum showed no significant decrease in virus titer 
following storage at 22 ° to 28°C., 4°C.,  and -70°C.,  respectively, for periods 
of at least 6 hours, 48 hours, and 78 days, respectiveIy. 
In neutralization tests as carried out in this study, mixtures of serum dilutions 
and virus dilutions were held for periods no longer than 1 hour at 4°C. and for 
additional periods  no  longer than 30  minutes at room  temperature  (22 °  to 
28°C.).  It seems evident, in the light of the experiments just described, that 
during  these  intervals  it  would  be exceedingly unl/kely  that  any significant 
inactivation of virus occurred and consequently it appears possible to calculate, 
within the limits of expected variation, the amount of virus neutralized. 
NeutraUnation of PVM by Immune Serum 
In a  previous paper (1)  it was shown that  PVM is readily neutralized by 
specific immune serum as determined by the results of tests in mice with mix- 
tures of the virus and serum.  Despite the clear qualitative significance of the 
results previously described, no attempt was made at that time to establish the 
quantitative limits of neutralization tests with this virus. 
In the intervening period experiments designed to yield information on the 
reproducibility  of immune serum dilution  end points  in  neutralization  tests 
with PVM have been carried out and studies on the relationship between serum 
titer and the amount of virus used in such tests have been made. 
Neutralization tests were carried out as described above, with PVM and selected immune 
sera obtained from three species.  It is important to emphasize that both the serum dilutions 
and the virus dilutions were varied with respect to each other in each test in order that the 
whole range of the reaction might be studied.  Each mixture of serum and virus was tested 
in a group of six mice.  At least three separate neutralization tests under these conditions 
were performed with each serum so that the four or more end points found in one test could 
be compared with end points obtained in other tests on the same serum and the variations 
analyzed. 
The results of three separate neutralization  tests with PVlVl and a  pool of 
anti PVM cotton rat serum (C) are shown in Table V.  The results obtained in 
these tests were analogous to those obtained in similar experiments with rabbit 
and human immune serum; because they serve as typical examples they are 
presented in detail.  It will be observed that with approximately equal quan- 
tities of virus the serum dilution end points found in each of the three tests were 
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served end points were almost identical in each test.  It should be noted also, 
that whereas the decremental change in the quantity of virus used in these tests 
was log 0.5, the incremental change in the serum dilution end point had a mean 
value of only log 0.33.  This  indicates clearly that,  under  the  conditions of 
these experiments, the relation between the serum dilution end point and the 
quantity of virus used was not one of simple multiple proportions.  Additional 
comments on this point will be given below. 
The results obtained in all of the neutralization tests carried out with a  pool 
of immune cotton rat serum (C), an anti PVM rabbit serum (R), and an immune 
human serum  (H), are presented graphically in Fig. 1.  The logarithm of the 
M.S. 50 serum dilution end point obtained in each test was plotted against the 
logarithm of the number of M.S. 50 doses of virus used.  It will be seen that the 
various serum  dilution end points found  with each  of the  three sera studied 
TABLE V 
Results of Multiple Neutralization Tests with PVM and Immune Cotton Rat Serum 
Dilution 
Log 
--1.3 
--1.8 
--2.3 
--2.8 
--3.3 
Geometric 
mean .... 
Virus  Serum dilution  end point M.S.  50 
Approxi- 
mate 
M.S. 50 
doses 
Log 
2.4 
1.9 
1.4 
0.9 
0.4 
1.4 
Change  in 
amount 
of virus 
per step 
I  LOg  ~ 
0;,5 
7' 
0.5 
1:269 
1:375 
1:1440 
1:1530 
1:6400 
Test  No. 
1:185 
1:387 
1:1360 
1:4750 
1:3910 
1:238 
1:440 
1:1750 
1:2280 
Geometric 
mean 
LOg 
--2.36 
--2.59 
--3.18 
--3.41 
--3.69 
-3.0 
Mean 
Deviation 
Log 
-t-0.06 
:t:0.03 
q-0.04 
±0.18 
q-0.10 
~0.08 
Change 
In mean 
end  point 
per step 
Log 
0.23 
0.59 
0.23 
0.28 
0.33 
tended to fall along straight lines when the quantity of virus used in each test 
was taken into account and both variables were plotted as logarithms. 
In previous communications (5, 8) it was shown that there was a linear exponential relation- 
ship between the immune serum dilution end point and the quantity of influenza A  virus 
neutralized.  It was found that under fixed experimental conditions the whole course of the 
neutralization of influenza A virus by specific immune serum could be expressed by the equa- 
tion 
yffi bx  ~ 
in which y was the quantity of virus neutralized, b the intercept on the Y axis, x the serum 
dilution end point, and a a constant.  With either ferret, rabbit, or human immune serum and 
influenza A virus it was shown that this equation could be applied; in each case the exponent 
a was found to have a value -- 1.44.  It is apparent that the slope of the straight line, which 
is a graphic expression of the linear relationship between the two variables, x and y, is deter- 
mined by the value of the exponent  a. 36  PIC~OmA  VIRUS Or  raCE  (I'Ve).  I 
From the results  shown  in Fig.  1  it seemed evident that  there  was a  linear 
relationship between the immune serum dilution end point and the quantity of 
PVM  neutralized  which  was  closely similar  to  that  found  in  studies  on  the 
neutralization of influenza A virus.  It was of interest to determine the slope of 
the  straight  line which expressed this relationship  graphically with PV'M and 
to  compare  it with the slope  of the  neutralization  line found previously with 
influenza A  virus. 
b%  •  x  C 
x  oH 
,.°-  o  ",  .  A\  ,,o  ..\\ 
%%  Q  • 
o  ',,  "\N 
,q 
o  I 
-1.0  -2.0  -3.0  -4.0 
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FIo.  1.  Results of  multiple neutralization tests  with immune sera obtained from three 
different species and PVM.  C  =  cotton rat serum.  R  =  rabbit serum.  H  =  human serum, 
Each end point was calculated from the results obtained in thirty or more mice.  Each serum 
virus mixture was tested in a group of six mice. 
When the variables are expressed as logarithms the equation given above takes the form 
logb  =  logy-  (alogx) 
and as such can be used readily for the calculation of the value of the constant a provided the 
other values are known.  In the case of the cotton rat serum (C), when b, the intercept on the 
Y axis, was taken to be log 5.94 it was found that the mean value of the exponent a for all the 
experimentally determined points was 1.44.  With the rabbit serum (R), when b =  log 5.65, 
the mean value for a was again 1.44, and finally for the human serum (H), when b --- log 4.01 
the mean value for a was also 1.44.  Thus it appears that the slope of the neutralization line 
determined for PVM was identical to that previously found for influenza A virus. 
Each of the straight fines shown in Fig. 1 was drawn so that it would correspond with the 
constants given above for the particular serum under consideration.  It appears evident that ~RANK  L.  HORSFALL~  fR.,  AND  EDWARD  C.  CURNEN  37 
there is no systematic deviation of the experimental end points from the corresponding calcu- 
lated lines, with the exception only of three instances in which log 0.75 M.S. 50 doses or less 
of virus were neutralized by rabbit serum (R).  Sixteen end points obtained with cotton rat 
serum (C) and PVIVI are shown in Fig. 1.  These end points had, on the X or serum dilution 
end point axis, a mean deviation of log 4-0.14 from the calculated line (C).  Sixteen end points 
obtained with rabbit serum  (R)  and PVM are also shown.  These end points had, on the 
X axis, a mean deviation of log 4-0:24 from the calculated line (R).  Finally twelve end points 
obtained with human serum  (H) and PVM are shown.  These end points had, on the same 
axis, a mean deviation of log 4-0.13 from the calculated line (H). 
In order to determine the reproducibility of immune serum dilution end points 
in neutralization tests with PVM, various computations similar to those used 
in determining the reproducibility of titration end points with the virus were 
TABLE VI 
Deviations, Variances, and Standard Deviations of Neutralization Tests 
with PVM and Immune  Sera 
Serum 
•  Immuni-  .  S~ec:es  zal:'cn 
Cotton rat .... I  LN. 
Rabbit .......  I  I.P. 
Human ....... ]  -- 
Total  ............... 
No. of  ....... 
tests 
16 
16 
12 
44 
Neutral-  ] 
ization  ] 
capacity 
of serum 
Log 
M.S. 50 
calcu- 
lated* 
5.94 
5.65 
4.01 
5.20 
Standard 
neutral- 
ization 
titer of 
serum 
Log 
M.S. 50 
ealcu- 
lated~ 
Deviation of observed 
from calculated end 
pointsi~  [  axis 
Great-  I.e~st  e: t  Mean 
--3.07  0.00  1+0.4~  4-0.1, 
--2.90  0.00  1+0.5;  4-0.2, 
--1.76  0.00  --0.3!  4-0.1: 
--2.84  0.00  [4-0.4.  4-0.1; 
Variance 
V 
0.032 
0.086 
0.031 
O. 049 
Standard 
deviation 
0.179 
0.293 
0.175 
0.221 
* Neutralizing capacity calculated from intercept (b) on Y axis, when exponent a  -- 1.44. 
Standard neutralization titer calculated against log 1.5 M.S. 50 doses of virus. 
carried out with  the available data.  The results of those calculations which 
were  essential to  the  determination of variation in neutralization end points 
with  PVM are presented in Table VI.  The  least and greatest deviations of 
indivldual end points for each serum from the calculated value, on the X  axis, 
as well as the mean deviation found for each serum, are shown.  The variance, 
V, and standard deviation, ~,, of end points computed for each serum are also 
given. 
It will be seen that  the means  of the  least and greatest deviations for the 
entire series were log 0.00 and log q-0.45, respectively, and that the mean devia- 
tion  of all the end points was log -4-0.18.  It will also be  observed  that  the 
standard deviation of the distribution of the serum  dilution end points in  the 
whole serieswas 0.221 log units.  From the considerations given in the first sec- 
tion of this paper  it  can  be  shown  that with  individual serum  dilution end 3S  P~rMo~  v~us  oF  ~ic~  (Pw,).  i 
points on two sera, a difference of 2 X  1.415 X  0.221 =  0.626 log units or more 
can be taken to indicate that the chances are at least 19 out of 20 that the anti- 
body concentrations of the sera were  not identical, provided the amount of 
virus used was similar inbothtests.  A difference of 0.626 log units is obviously 
equivalent to a fourfold difference between conventional serum titers as  com- 
monly expressed. 
On the basis of these considerations it can be shown that there is a high proba- 
bility that the differences between the standard neutralization titers shown in 
3.0  ~  x C 
~*i.0  x 
0  I  - 
-2.(I  -3.O  -411 
LO~ ~er~urn  dilution  end  poinT, 
FIo.  2.  Results  of  multiple  neutralization  tests  with  immune  cotton  rat  serum  (C) 
and PVM.  Each end point was calculated from the results obtained in fifteen or more mice. 
Each serum virus mixture was tested in a  group of three mice. 
Table VI for the three immune sera were significant, and indicate that the sere 
studied did actually contain different concentrations of antibody against PVM. 
The probability is at least 0.97 that cotton rat serum (C) contained more anti- 
body than rabbit serum (9.).  Similarly the probability is at least 0.999 that 
human serum (H) contained less antibody than either of the other sera. 
It is manifestly impracticable to use a group of six mice to test each mixture 
of serum and virus when large numbers of neutralization tests with PVM are 
carried out.  Consequently it was of interest and of practical importance to 
determine the  reproducibility of serum dilution end points in neutralization 
tests with PVM when a group of three instead of six mice was used to test each 
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To accomplish this two additional series of M.S. 50 serum dilution end points were deter- 
mined from the results of each of the neutralization tests described above which were carried 
out with cotton rat serum (C) and PVM.  In the first series only the results obtained in the 
three odd numbered mice in each group of six were used.  In the second series only the results 
obtained with the three even numbered mice were employed.  The logarithms of the serum 
dilution end points found in both series were plotted against the logarithm of the number of 
M.S. 50 doses of virus used in each test and the results are shown in Fig. 2,  A straight line 
corresponding exactly to line (C) in Fig. 1 was drawn.  It is evident that with neither series 
of end points is there any systematic deviation from line (C) which, it will be recalled, was 
derived from results obtained with the same serum in groups of six mice.  With the 32 end 
points shown in Fig. 2 the mean deviation on the X axis, from line (C) was log o-0.17. 
Various computations analogous to those described above were carried out 
with the results obtained in groups of three mice.  The results of these calcula- 
tions are presented in Table VII.  It will be seen that the standard deviation of 
TABLE VII 
Comparison  of Computations  on End Points with Groups of Six and Groups  of Three Mi~e in 
Neutralization  Tests with PVM 
No. of 
mice per 
group 
6 
3 
3 
3 or6 
No. of 
M.S. 50 
end 
points* 
16 
32 
32 
48 
Comparison 
Observed  vs.  calculated 
(line C) 
Same 
Odd  vs.  even  numbered 
groups 
6 mouse vs. 3 mouse group., 
Deviation of neutralization 
end points on X axis 
Log 
Least  Greatest  Mean 
0.00  +0.42  --0.14 
0.00  +0.42  0-0.17 
0.00  +0.18  0-0.07 
0.00  +0.23  0-0.09 
'ar~nc( 
---f- 
0.032 
0.045 
0.019 
0.014 
Standard 
deviation 
0.179 
0.214 
0.138 
0.120 
* All neutralization tests were carried out with cotton rat serum (C). 
the distribution of serum dilution end points in neutralization tests employing 
groups of three mice was 0.214 log units.  This is only slightly different from 
the corresponding value, 0.179 log units, found in identical neutralization tests 
employing groups of six mice.  It wiU be noted also that when the two series of 
end points obtained in different groups of three mice each were compared the 
mean deviation was no greater than log 4-0.07 and the standard deviation was 
only 0.138  log units.  Similarly when  the end points obtained with groups of 
three and six mice were compared the mean deviation was only log -4-0.09 and 
the standard deviation 0.120 log units. 
These results indicate that the reproducibility of serum dilution end points in 
neutralization tests with PVM was not significantly greater when groups of six 
mice were used to test each mixture of serum and virus than when groups of 
three mice were similarly used.  Consequently, it can be concluded that accu- 
rate serum dilution end points can be obtained with this virus when mixtures are 40  I"NEUMONrA VmUS o~ race  (PvM).  I 
tested in groups of three mice.  It will be evident from the studies described in 
the accompanying paper (9) that this finding was of considerable practical value. 
DISCUSSI6N 
The results of the experiments described in this paper indicate the degree of 
precision which was achieved in the determination of virus titration end points 
with PVM and immune serum dilution end points in neutralization tests with 
this virus under the stated experimental conditions.  Knowledge of the repro- 
ducibility of either end point is obviously essential for an accurate interpre- 
tation  of  the  significance  of  differences  between  end  points  unless  such 
differences are sufficiently great as to leave no doubt concerning their reality. 
Attempts to study, in as quantitative a  manner as possible, certain  of the 
biological phenomena associated with acute respiratory disease have made nec- 
essary the employment of standardized experimental precedures and the acqui- 
sition of reliable information on the degree of variation which may be expected 
in measurements based on in dvo tests.  In the case of PVM  and neutralizing 
antibodies directed against this virus, the present studies appear to provide this 
information and make possible an accurate assessment of the significance of 
experimental data.  In the accompanying paper (9) direct use of the computa- 
tions presented in this report will be made. 
The finding that there was, under the experimental conditions described, a 
linear exponential relationship between the immune serum dilution end point 
and the amount of PVM used in a neutralization test has both theoretical and 
practical implications. 
It seems of considerable interest that under similar experimental conditions 
the linear relationship between the serum dilution end point and the quantity of 
virus used in neutralization tests should be the same with PVM and specific 
immune serum against it, as with influenza A virus and specific immune serum 
against it (5, 8).  Furthermore, this relationship appears to be constant irre- 
spective of the species from which either variety of immune serum is obtained. 
It is recognized that both PVM and influenza A virus are considered to be 
strictly pneumotropic agents, and  that the  quantitative neutralization tests 
which revealed this relationship with both were carried out in a single animal 
species,  i.e. mice, by means of a single route of inoculation, i.e. the intranasal. 
In a recent paper Morgan (10)has shown a sim'flar linear relationship in neutral- 
ization tests with Western equine encephalomyelitis virus  and its  antiserum. 
It seems of interest that although her tests also were carried out in mice both 
the  intraperitoneal  aad  intracerebral  routes  of  inoculation  were  employed. 
Whether a  similar relationship will be apparent when still other viruses are 
studied in different species by various routes of inoculation must await further 
investigation. 
Although it has been shown that with PVM, as with influenza A virus, the FRANK L.  HORSFALL, JR.,  AND ZEDWARD C.  CURNEN  41 
neutralization titer obtained for a particular immune serum is a function of the 
quantity of virus used to determine it, this should not be taken to indicate that 
serum  neutralization  titers  are  comparable only when  tests  are  carried  out 
against identical amounts of virus.  As can be seen from the data presented in 
this paper, the quantity of PVM used in a neutralization test can be varied as 
much as  sevenfold (i.e.  log  ~  0.42)  without  causing a  definitely significant 
alteration (i.e. a fourfold change) in the neutralization titer  of a  given serum. 
Moreover it appears of importance to point out that in neutralization tests car- 
ried out as described with PVM, as well as in similar tests with influenza A virus 
(8), a  tenfold increase in the quantity of virus used did not result in a  tenfold 
decrease in the neutralization titer of a serum, but instead caused only a  fivefold 
decrease in titer. 
It is apparent, however, that by varying the quantity of virus used in a neu- 
tralization test over a wide range, it is possible to obtain very different neutrali- 
zation titers with the same serum.  If in one test 10 while in another test 1000 
M.S. 50 doses of virus are employed, the neutralization titer obtained with a 
particular serum should be, within the limits of expected variation, 25 times 
higher in the former test than in the latter. 
This study on pneumonia virus of mice (PVM) was carried out in order to 
obtain as accurate data as possible on the degree of variation which may be 
expected in titrations of the virus or of antibodies against it in rico.  It is be- 
lieved that the knowledge gained will facilitate further investigations on this 
latent pneumotropic virus and make possible a  more exact assessment of the 
significance of experimental results obtained with the agent. 
The reproducibility of 50 per cent maximum score titration end points with 
PVKI in mice is such that the chances are 19 out of 20 that a difference of 1.084 
log units (i.e. a twelvefold difference) in the end points obtained in two separate 
titrations is significant.  The reproducibility of 50 per cent maximum score 
serum dilution end points in neutralization tests with PVM in mice is such that 
the chances are 19 out of 20 that a difference of 0.626 log units (i.e. a fourfold 
difference) in the end points obtained with two sera against similar amounts of 
virus is significant. 
It was found that there is a linear exponential relationship between the serum 
dilution end point and the quantity of PVM used in a neutralization test.  This 
relationship appears to be identical with immune serum obtained from different 
animal species, and appears also to be identical to the linear relationship de- 
scribed previously in similar studies with influenza A virus. 
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